eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
EXOZ stock price ended at $10.37 on 月曜日, after dropping 1.33%
On the latest trading day Feb 09, 2026, the stock price of EXOZ fell by 1.33%, dropping from $10.37 to $10.37. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $10.37 and a high of $10.37. On the latest trading day, the trading volume for EXOZ decreased by 390 shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 512 shares were traded, with a market value of approximately $87.0M.